The Bioengineered Protein Drugs Market report provides quantitative analysis of the current market and estimates.
PORTLAND, OREGON, USA, Aug. 5, 2022 /EINPresswire.com/ — Proteins play a crucial role in maintaining the structural and functional aspects of an individual organism. The long chain of amino acids makes up a protein molecule and regulates all biological functions such as metabolic reactions, DNA replication and other vital expression functions in the body. Bioengineered proteins are designed as fundamental participants in all biological processes, represent potent therapeutic agents and include a wide range of products such as growth factors, hormones, vaccines, monoclonal antibodies, cytokines and a few others. These specialty drugs are attracting attention in the pharmaceutical industries due to their specificity, safety, bioreactivity, and success rate in treating life-threatening illnesses and injuries. Rising prevalence of diseases such as cancer, diabetes, heart disease, asthma, and others is the major driver of the bioengineered protein drug market.
𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
Bayer Health Pharmaceutical
Eli Lilly and Co.
Fresenius Kabi United States
Johnsons and Johnsons
Merck and Co Inc.,
𝐆𝐞𝐭 𝐔𝐩 𝐓𝐨 𝟏𝟎% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭, 𝐓𝐢𝐥𝐥 𝐭𝐡𝐞 𝐃𝐚𝐭𝐞 𝟐𝟎𝐭𝐡 𝐨𝐟 𝐀𝐮𝐠𝐮𝐬𝐭 𝟐𝟎𝟐𝟐.
The delivery of these biologically active proteins to target organs and tissues is a major challenge. Bioengineered protein drugs are making significant progress as new treatments for a number of diseases such as chronic diseases, cancer, asthma and others. Thus, efficient drug delivery methods using technologically advanced vehicles such as micelles, liposomes, and hydrogels are helping to drive the growth of this market.
The report segments the bioengineered protein drug market on the basis of drug types, diseases, technologies, drug delivery methods, and geography. Based on drug types, the market is further segmented into recombinant protein drugs, peptide hormones, vaccines, therapeutic enzymes, monoclonal antibodies, cytokines, replacement proteins, peptide antibiotics, and blood products. The type of monoclonal antibodies is the most attractive type of drug due to its increased use in therapy for autoimmune diseases, cancer, and inflammatory diseases. According to disease segment, the market has been categorized into diabetes, cancer, skin diseases, blood disorders, heart diseases, neurodegenerative diseases, respiratory diseases, infectious diseases, congenital diseases, autoimmune diseases, arthritis, and others.
On the basis of technology, the market is further segmented into fractionation, bioreactors and microbial cell fermentation, genetic engineering, genetically modified organisms (GMOs), pharming, bioengineered protein drugs produced by transgenic microorganisms, plants and animals, cell culture and others. Advancements in manufacturing technologies such as GMOs and cell cultures are driving the growth of the market. Based on drug delivery methods, the market has been categorized into traditional methods and novel approaches. A geographic breakdown and in-depth analysis of each of the aforementioned segments has been included for North America, Europe, Asia-Pacific and LAMEA. North America dominates the bioengineered protein drug market and the United States is the leading country in this market owing to the high technological advancements and extensive R&D performed for the manufacture of bioengineered protein drug. bio-engineering.
𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘
• A comprehensive analysis of factors driving and restraining the growth of the Global Bioengineered Protein Drugs Market is provided.
• The projections in this report are made by analyzing the current market trends and the market potential for the forecast period of 2014-2020, in terms of value.
• A comprehensive analysis of drug types, diseases, technologies, drug delivery methods, and geographical segments helps to identify growth opportunities in the global Bioengineered Protein Drugs market
• Competitive intelligence (of major bio-engineered protein drug manufacturers) helps to understand the competitive scenario across geographies
• A SWOT analysis of key market players is provided to illustrate the business strategies adopted by leading companies
• The report provides quantitative analysis of the current market and estimates through 2014-2020 that help identify existing market opportunities to capitalize on
𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬
Dialysis Concentrates Market
Cardiovascular ultrasound market in France
𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 :
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unrivaled quality of “market research reports” and “Business Intelligence solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market areas. AMR offers its services in 11 industry sectors, including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverage, Energy & Power, semiconductors and electronics, automotive and transport, ICT and media, aerospace and defense and BFSI.
We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. Allied Market Research CEO Pawan Kumar helps inspire and encourage everyone associated with the company to maintain high quality data and help clients in every way possible to achieve success. All data presented in the reports we publish are drawn from primary interviews with senior executives from leading companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.
Allied Analytics LLP
write to us here
Visit us on social media: